[Potentialization of isoprenaline by 6-hydroxydopamine and reserpine association].
D000818:Animals; D004298:Dopamine / Q000494:pharmacology*; D004357:Drug Synergism; D004386:Duodenum / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology*; D007552:Isotonic Solutions; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology*; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000502:physiology; D013997:Time Factors
D007552:Isotonic Solutions; D012110:Reserpine; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine
Potentialisation de l'isoprénaline par l'association 6-hydroxydopamine et réserpine.